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CASE REPORT
Primary intestinal lymphangiectasia is a congen-
ital disease that is attributed to the obstruction of
lymph drainage from the small intestine, and
lacteal dilation that distorts the villous architec-
ture. Lymphatic duct obstruction and elevated
intestinal lymphatic pressure cause lymphatic leak-
age into the intestinal lumen, which can result in
malabsorption of nutrients that are transported
by the lymphatics, including fat-soluble vitamins.
Its manifestation is determined by the anatomical
location and extent of abnormal lymphatic ducts.
Diagnosis is confirmed by endoscopic biopsy and
histology of the intestine that show dilated lymph
ducts and deformed villi.
We report a child with intestinal lymphang-
iectasia who presented with hypocalcemia and
episodes of tetany. Secondary hyperparathyroidism
and decreased bone density were noted. She was
treated with a special formula that contained a
high concentration of medium chain triglyceride
(MCT). After vitamin D deficiency was confirmed
as a complication of intestinal lymphangiectasia,
supplements were administered, which resulted
in improvement.
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Primary intestinal lymphangiectasia is a rare disease of children, which is characterized by chronic diar-
rhea and complicated with malnutrition, including fat-soluble vitamin deficiency. We report a girl aged 
4 years and 8 months who was diagnosed with the disease by endoscopic duodenal biopsy at 8 months of
age. She presented initially with chronic diarrhea at 4 months of age. Generalized edema with hypoalbu-
minemia frequently occurred despite regular albumin supplements. Multiple vitamins initially were not
supplied regularly. Episodes of tetany caused by hypocalcemia developed 4 years after the diagnosis of 
intestinal lymphangiectasia. Imaging study (long-bone X-ray and dual-energy X-ray absorptiometry) 
revealed low bone density. Complicated vitamin D deficiency [low serum 25-hydroxy vitamin D concen-
tration (< 12.48 mmol/L, the detection limit)] and secondary hyperparathyroidism were confirmed via
blood testing. Vitamin D supplementation for 3 months improved her bone density, secondary hyper-
parathyroidism and frequent tetany. Vitamin D status should be monitored in patients with intestinal
lymphangiectasia. [J Formos Med Assoc 2009;108(10):814–818]
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Case Report
The patient was a girl aged 4 years and 8 months,
who presented with chronic greasy diarrhea since
the age of 4 months, which was complicated with
hypoalbuminemia and generalized edema. She
had not undergone previous surgery or radio-
therapy. Primary intestinal lymphangiectasia was
diagnosed by an endoscopic duodenal biopsy 
at 8 months of age. Meanwhile, elevated fecal
α1-antitrypsin secretion was detected (16.66 mg/g;
normal range, 0–2.957 mg/g). The extent of lym-
phangiectasia was from the second portion of
the duodenum to the ileum, as revealed by upper
endoscopy, upper gastrointestinal series, small
bowel follow-through, and colon barium enema
study. No proteinuria was noted. Electrocardio-
graphy and chest radiography were normal.
Abdominal ultrasonography showed diffuse ede-
matous bowel wall and ascites, and no mass 
lesion that could compress the lymphatic circu-
lation. Since then, she has had regular follow-up
at the outpatient clinic. She has been admitted
several times for albumin supplements, and she
has also taken a special formula that contained 
a high concentration of MCT (Alfare: 24 g fat,
16.6 g protein, and 290 IU vitamin D per 100 g;
MCT: 48% of fat) supplemented with SENTOSA
Hi-calorie dietetic oil powder (71.2 g fat and
2.2 g protein per 100 g; ratio of MCT oil to soy-
bean oil, 6:1; free of vitamins). Vitamin supple-
ments were given occasionally, which were not
included in such formulas.
She had three episodes of tetany during the
previous 2 months despite regular albumin sup-
plements. Every episode of tetany subsided after
supportive treatment. She denied any special
medication history. At admission, a puffy eyelid,
pitting edema over both pretibial areas, distended
abdomen without shifting dullness, and genu val-
gum were noted upon physical examination. The
Chvostek and Trousseau signs were negative. Her
weight (17 kg) was within the 50th to 75th per-
centiles, and her height (100 cm) was within the
10th to 25th percentiles for her age.
Blood examination showed lymphopenia
(7.78 × 109 cells/L), hypoglobulinemia (IgA,
< 0.275 g/L; IgG, 1.84 g/L; IgM, 0.248 g/L), hypo-
albuminemia (25.8 g/L), elevated liver enzymes
(aspartate aminotransferase, 95 U/L; alanine
aminotransferase, 142 U/L), and low concentra-
tions of total calcium (2 mmol/L) and ionized
calcium (0.35 mmol/L). The concentrations of
corrected serum total calcium (2.28 mmol/L),
phosphorus (1.615 mmol/L) and magnesium
(0.92 mmol/L) were at a relatively low normal
limit. Follow-up concentrations of total and 
ionized calcium level were still low, at 2.025 and
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Figure 1. (A) Endoscopic image shows dilated lymphatic channels filled with proteinaceous material. (B) Section reveals
marked dilatation of lymphatic ducts that involved the mucosa (hematoxylin & eosin, 40×; black arrow, distorted villous;
white arrow, dilated lymph duct with proteinaceous material).
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1.11 mmol/L, respectively. There was no alkalosis,
excess urinary calcium, or phosphorus loss.
In addition, the parathyroid hormone (PTH)
concentration was elevated (390 ng/L; normal
range, 12–72 ng/L) and serum 25-hydroxy vita-
min D [25(OH) D] concentration was markedly
low (< 12.48 mmol/L, the detection limit; normal
range, 24.21–104.08 nmol/L). Serum concentra-
tion of 1,25 dihydroxy vitamin D [1,25(OH)2 D]
was normal (91.23 pmol/L; normal range,
41.34–144.56 pmol/L).
Abdominal ultrasonography showed a dilated
bowel loop with edematous bowel wall and mild
ascites. Panendoscopy showed acute and chronic
inflammatory changes and elevated whitish, di-
lated lymphatic channels filled with proteina-
ceous material of the duodenum (Figure 1A). A
duodenal biopsy (Figure 1B) revealed dilated
lymphatic spaces that involved the lamina pro-
pria and muscularis mucosa, which was suggestive
of lymphangiectasia. A long bone survey showed
increased radio-opacity at the metaphyseal ends
near the epiphyses of both distal femurs, upper
and lower tibias, and both distal radii and ulnas.
Knee X-ray films (Figure 2A) showed mild pe-
riosteal elevation at both distal femurs. In addition,
dual-energy X-ray absorptiometry showed signif-
icantly decreased bone density of the lumbar spine
(0.472 g/cm2) (mean density for a 4-year-old girl
is 0.624 ± 0.04 g/cm2).1 Intestinal lymphangiec-
tasia complicated with vitamin D deficiency was
thus diagnosed.
Thereafter, intravenous multiple vitamins in-
cluding 400 IU ergocalciferol (vitamin D2) and
subcutaneous vitamin K were administered dur-
ing hospitalization. Oral vitamin D supplemen-
tation with 0.75 μg/day alfacalcidol and monthly
intramuscular multiple vitamins were given after
discharge from the hospital. Follow-up revealed a
decreased level of PTH (84.6 ng/L), normal levels
of serum total calcium (2.1 mmol/L) and corrected
total calcium (2.32 mmol/L), but hypoalbumine-
mia persisted (29 g/L). Knee X-rays (Figure 2B)
revealed less obvious high density at the meta-
physeal ends of the long bones, and no periosteal
reaction of the distal femur after 3 months of 
vitamin D supplementation. At present, she con-
tinues on 1 μg/day alfacalcidol, after dosage ad-
justment. Further follow-up has shown that PTH
(62.1 ng/L) and total calcium (2.26 mmol/L) are
within normal limits. Therefore, the treatment
has been maintained.
Discussion
Primary intestinal lymphangiectasia with protein-
losing enteropathy was diagnosed in this patient
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Figure 2. (A) Knee X-ray revealed increased density (arrow) at bilateral distal femoral and proximal tibia metaphyseal
ends, and periosteal elevation at initial presentation. (B) No more periosteal elevation (arrow) of the distal femoral
bones, and the high density of the metaphyseal ends are no longer obvious after supplementation with vitamin D for 
3 more months.
at 8 months of age. Although she was supple-
mented with a special formula, a low concentra-
tion of albumin persisted. Vitamin D deficiency
developed with frequent episodes of tetany and a
decreased concentration of ionized calcium, in-
creased concentration of PTH, and decreased bone
mineral density (BMD) and periosteal reaction at
the metaphyses near the epiphyses.
Primary intestinal lymphangiectasia is usually
diagnosed before 3 years of age. It is a congenital
disorder of the lymphatic system.2–5 If a large por-
tion of the small intestine is involved, protein-
losing enteropathy may occur, which may cause
edema.5,6 Based on fat malabsorption, vitamin D
deficiency with tetany, secondary hyperparathy-
roidism and a decrease in bone density are present,
as in our patient.
The medical treatment includes a high-
protein, low-fat diet with added MCT. MCT is 
absorbed directly into the portal system. The ab-
sence of fat in the lymphatics prevents the engorge-
ment of the lymphatic duct from rupture and
malabsorption.5,7,8
Our patient was diagnosed with vitamin D
deficiency, which is characterized by low plasma
levels of 25(OH) D, the major circulating metabo-
lite. However, the most potent bioactive metabo-
lite is 1,25(OH)2 D, whose concentration is
maintained until an extreme degree of vitamin D
depletion, by the compensatory effects of PTH.
Vitamin D deficiency over a prolonged period
leads to osteomalacia or rickets, whereas less severe
deficiency, accompanied by secondary hyper-
parathyroidism, causes osteopenia.9–11 Increased
PTH secretion is one of the earliest signs of insuf-
ficient stores of vitamin D, a physiological response
mediated through changes in serum ionized cal-
cium and serum 1,25(OH)2 D. PTH hypersecre-
tion may accelerate bone turnover rate, which may
induce bone resorption and a net loss of bone
minerals. We have used the BMD score to detect
bone mineral loss in our patient, based on the
significant inverse correlation of 25(OH) D and
BMD z scores in children.12 Furthermore, the
sclerotic change in our patient suggested growth
arrest during severe disease or recovery status 
of rickets, which might occur in vitamin D 
deficiency.
Solar radiation cannot significantly influence
the level of vitamin D. Moreover, increased dietary
intake might not be sufficient because of malab-
sorption. Therefore, the ideal way to combat 
vitamin D deficiency is supplementation. Con-
ventional oral replacement therapy is appropriate
in most patients. No matter what degree of fat
malabsorption exists, any vitamin D supplemen-
tation is associated with a significant increase in
25(OH) D concentration. 25(OH) D, 1,25(OH)2
D and alfacalcidol are superior to vitamin D3 in
patients with malabsorption, and all have similar
potency.9–11,13–16 When malabsorption occurs, a
higher oral dose is needed than that for preven-
tion (400–1000 IU/day vitamin D3). The level of
serum ionized calcium, 25(OH) D and PTH
should be monitored during therapy because 
of the risk of toxicity, and then the dose should
be adjusted. The current safe dose of vitamin 
D3 is 1000–2000 IU daily and 0.05 μg/kg/day
1,25(OH)2 D.9,10 Parenteral supplements should
be considered if oral treatment does not work
sufficiently. Intramuscular vitamin D injections
of 100,000 IU/month have long been used in 
patients with severe malabsorption.10
In conclusion, our patient with intestinal
lymphangiectasia had malabsorption of fat-soluble
vitamins that led to vitamin D deficiency.
Vitamin D deficiency should be screened in cases
of intestinal lymphangiectasia and routine sup-
plements are advised.6,10
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